Oral ferric maltol vs IV ferric carboxymaltose
Number of responders ‐ disease activity not stated (12 weeks) · IBD patients
Oral ferric maltol showed no clear difference in number of responders ‐ disease activity not stated (12 weeks) compared with IV ferric carboxymaltose (low certainty).
1 finding from 1 review
- Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes onlyRR 0.83 [0.65, 1.06]1 study · 252 participantsLow